These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7479210)

  • 1. Atracurium resistance in a critically Ill patient.
    Tschida SJ; Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):533-9. PubMed ID: 7479210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):540-5. PubMed ID: 7479211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to pancuronium after loss of atracurium-induced neuromuscular blockade.
    Kelly KJ; Clarens DM; Kohls PR; Nahum A; Vance-Bryan K
    Ann Pharmacother; 1993; 27(7-8):862-5. PubMed ID: 8364264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cis-atracurium requirements during prolonged administration to a child.
    Tobias JD
    Can J Anaesth; 1997 Jan; 44(1):82-4. PubMed ID: 8988829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation.
    O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C
    Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of constant 95% neuromuscular blockade by adjustable infusion rates of pancuronium and atracurium.
    Haraldsted VY; Nielsen JW; Madsen JV; Hasselstrøm L
    Br J Anaesth; 1988 Apr; 60(5):491-4. PubMed ID: 3377923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose requirements of continuous infusion of rocuronium and atracurium throughout orthotopic liver transplantation in humans.
    Weng XC; Zhou L; Fu YY; Zhu SM; He HL; Wu J
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):869-72. PubMed ID: 16130187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.
    Hoey LL; Joslin SM; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1995; 15(2):254-9. PubMed ID: 7624274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of the continuous infusion of cis-atracurium for neuromuscular blockade in the pediatric intensive care unit patient: efficacy and dosage requirements.
    Tobias JD
    Am J Ther; 1997; 4(9-10):287-90. PubMed ID: 10423621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of continuous infusion of vecuronium and atracurium in midline and paramedian laparotomies.
    Chaudhari LS; Shetty AN; Buddhi M; Krishnan G
    J Postgrad Med; 1999; 45(1):5-9. PubMed ID: 10734323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus guidelines for sustained neuromuscular blockade in critically ill children.
    Playfor S; Jenkins I; Boyles C; Choonara I; Davies G; Haywood T; Hinson G; Mayer A; Morton N; Ralph T; Wolf A;
    Paediatr Anaesth; 2007 Sep; 17(9):881-7. PubMed ID: 17683408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs.
    Martinez EA; Mealey KL; Wooldridge AA; Mercer DE; Cooper J; Slater MR; Hartsfield SM
    Am J Vet Res; 1996 Nov; 57(11):1623-6. PubMed ID: 8915441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular responses to neuromuscular blockade in the anemic ovine fetus.
    Shields LE; Brace RA
    J Matern Fetal Med; 1997; 6(4):195-9. PubMed ID: 9260114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of action of atracurium when given by infusion to critically ill children.
    Playfor SD; Thomas DA; Choonara I
    Paediatr Anaesth; 2000; 10(1):77-81. PubMed ID: 10632914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cis-atracurium to maintain moderate neuromuscular blockade in experimental pigs.
    Tutunaru A; Dupont J; Huberty V; Ibrahim M; Serteyn D; Sandersen C
    Vet Anaesth Analg; 2017 Jul; 44(4):910-914. PubMed ID: 28739108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.